|
1
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar
|
|
2
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar
|
|
3
|
Speetjens FM, Zeestraten EC, Kuppen PJ,
Melief CJ and van der Burg SH: Colorectal cancer vaccines in
clinical trials. Expert Rev Vaccines. 10:899–921. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lu G and Wang Y: Functional diversity of
mammalian type 2C protein phosphatase isoforms: new tales from an
old family. Clin Exp Pharmacol Physiol. 35:107–112. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li J, Yang Y, Peng Y, Austin RJ, van
Eyndhoven WG, Nguyen KC, Gabriele T, McCurrach ME, Marks JR, Hoey
T, Lowe SW and Powers S: Oncogenic properties of PPM1D located
within a breast cancer amplification epicenter at 17q23. Nat Genet.
31:133–134. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hirasawa A, Saito-Ohara F, Inoue J, Aoki
D, Susumu N, Yokoyama T, Nozawa S, Inazawa J and Imoto I:
Association of 17q21–q24 gain in ovarian clear cell adenocarcinomas
with poor prognosis and identification of PPM1D and APPBP2 as
likely amplification targets. Clin Cancer Res. 9:1995–2004.
2003.
|
|
7
|
Saito-Ohara F, Imoto I, Inoue J, Hosoi H,
Nakagawara A, Sugimoto T and Inazawa J: PPM1D is a potential target
for 17q gain in neuroblastoma. Cancer Res. 63:1876–1883.
2003.PubMed/NCBI
|
|
8
|
Demidov ON, Kek C, Shreeram S, Timofeev O,
Fornace AJ, Appella E and Bulavin DV: The role of the MKK6/p38 MAPK
pathway in Wip1-dependent regulation of ErbB2-driven mammary gland
tumorigenesis. Oncogene. 26:2502–2506. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Morikawa T, Kuchiba A, Qian ZR,
Mino-Kenudson M, Hornick JL, Yamauchi M, Imamura Y, Liao X,
Nishihara R, Meyerhardt JA, Fuchs CS and Ogino S: Prognostic
significance and molecular associations of tumor growth pattern in
colorectal cancer. Ann Surg Oncol. 19:1944–1953. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Morikawa T, Kuchiba A, Yamauchi M,
Meyerhardt JA, Shima K, Nosho K, Chan AT, Giovannucci E, Fuchs CS
and Ogino S: Association of CTNNB1 (beta-catenin) alterations, body
mass index, and physical activity with survival in patients with
colorectal cancer. JAMA. 305:1685–1694. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Weichert W, Röske A, Gekeler V, Beckers T,
Ebert MP, Pross M, Dietel M, Denkert C and Röcken C: Association of
patterns of class I histone deacetylase expression with patient
prognosis in gastric cancer: a retrospective analysis. Lancet
Oncol. 9:139–148. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Loukopoulos P, Shibata T, Katoh H, Kokubu
A, Sakamoto M, Yamazaki K, Kosuge T, Kanai Y, Hosoda F, Imoto I,
Ohki M, Inazawa J and Hirohashi S: Genome-wide array-based
comparative genomic hybridization analysis of pancreatic
adenocarcinoma: identification of genetic indicators that predict
patient outcome. Cancer Sci. 98:392–400. 2007. View Article : Google Scholar
|
|
13
|
Wang P, Rao J, Yang H, Zhao H and Yang L:
Wip1 over-expression correlated with TP53/p14(ARF) pathway
disruption in human astrocytomas. J Surg Oncol. 104:679–684. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yu E, Ahn YS, Jang SJ, Kim MJ, Yoon HS,
Gong G and Choi J: Overexpression of the wip1 gene abrogates the
p38 MAPK/p53/Wip1 pathway and silences p16 expression in human
breast cancers. Breast Cancer Res Treat. 101:269–278. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Satoh N, Maniwa Y, Bermudez VP, Nishimura
K, Nishio W, Yoshimura M, Okita Y, Ohbayashi C, Hurwitz J and
Hayashi Y: Oncogenic phosphatase Wip1 is a novel prognostic marker
for lung adenocarcinoma patient survival. Cancer Sci.
102:1101–1106. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hu W, Feng Z, Modica I, Klimstra DS, Song
L, Allen PJ, Brennan MF, Levine AJ and Tang LH: Gene amplifications
in well-differentiated pancreatic neuroendocrine tumors inactivate
the p53 pathway. Genes Cancer. 1:360–368. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Castellino RC, De Bortoli M, Lu X, Moon
SH, Nguyen TA, Shepard MA, Rao PH, Donehower LA and Kim JY:
Medulloblastomas overexpress the p53-inactivating oncogene
WIP1/PPM1D. J Neurooncol. 86:245–256. 2008. View Article : Google Scholar : PubMed/NCBI
|
